Biotechnology company developing engineered immune-cell therapies, particularly off-the-shelf CAR-NK therapies for autoimmune diseases
Biotechnology company developing engineered immune-cell therapies, particularly off-the-shelf CAR-NK therapies for autoimmune diseases. Its platform uses rapid prototyping, synthetic biology, engineered receptors, and data-driven screening to design cell therapies with tailored potency, improved safety, and broader patient access. Earlier company materials also describe applications in solid-tumor treatment.